Comparison of simultaneous integrated tumor bed boost and sequential boost during conventional fractionated whole-breast irradiation after breast-conserving surgery

Dan-Qiong Wang , Yu-Chun Song , Zi-Han Qiu , Hao Jing , Hui Fang , Yu Tang , Yong-Wen Song , Yue-Ping Liu , Shu-Nan Qi , Yuan Tang , Ning-Ning Lu , Bo Chen , Yi-Rui Zhai , Wen-Wen Zhang , Xin Liu , Si-Ye Chen , Zhuan-Bo Yang , Guang-Yi Sun , Xu-Ran Zhao , Zhi-Hui Zhang , Ye-Xiong Li , Shu-Lian Wang

MedScience ››

PDF (778KB)
MedScience ›› DOI: 10.1007/s11684-026-1258-3
RESEARCH ARTICLE
Comparison of simultaneous integrated tumor bed boost and sequential boost during conventional fractionated whole-breast irradiation after breast-conserving surgery
Author information +
History +
PDF (778KB)

Abstract

To compare the safety and efficacy of simultaneous integrated boost (SIB) and sequential boost (SeB) during conventional fractionated whole-breast irradiation (CF-WBI) after breast-conserving surgery. In total, 362 patients receiving CF-WBI following SeB and 272 receiving CF-WBI with SIB between 2010 and 2018 were included. All patients received 50 Gy in 25 fractions to the whole breast, with either 60 Gy in 25 fractions (SIB) or 10 Gy in 5 fractions (SeB) to the tumor-bed. Toxicities were assessed by CTCAE v3.0, and cosmetic outcomes by the Harvard scale. The outcomes analyzed included survival outcomes, treatment-related toxicities, and cosmetic outcomes. After a median follow-up of 92 months, no significant differences were observed between SIB and SeB in 5-year local control (LC) (98.2% vs. 97.8%), local-regional control (LRC) (95.6% vs. 97.1%), disease-free survival (DFS) (95.2% vs. 93.1%), overall survival (OS) (98.9% vs. 98.0%), and breast-conserving surgery(BCS) (99.3% vs. 98.6%). Inverse probability of treatment weighting (IPTW) analyses confirmed these findings. Rates of breast induration, fair or poor cosmesis result, and grade ⩾ 2 skin toxicity, pneumonitis, breast swelling, breast pain, lymphedema, and shoulder mobility were comparable between groups. Compared with SeB, SIB is an alternative approach with comparable survival outcomes and toxicities but a short treatment period. Further follow-up is needed to assess long-term outcomes.

Keywords

breast cancer / simultaneous integrated tumor bed boost / sequential tumor bed boost / conventional fractionated whole-breast irradiation

Cite this article

Download citation ▾
Dan-Qiong Wang, Yu-Chun Song, Zi-Han Qiu, Hao Jing, Hui Fang, Yu Tang, Yong-Wen Song, Yue-Ping Liu, Shu-Nan Qi, Yuan Tang, Ning-Ning Lu, Bo Chen, Yi-Rui Zhai, Wen-Wen Zhang, Xin Liu, Si-Ye Chen, Zhuan-Bo Yang, Guang-Yi Sun, Xu-Ran Zhao, Zhi-Hui Zhang, Ye-Xiong Li, Shu-Lian Wang. Comparison of simultaneous integrated tumor bed boost and sequential boost during conventional fractionated whole-breast irradiation after breast-conserving surgery. MedScience DOI:10.1007/s11684-026-1258-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

Rights & permissions

Higher Education Press 2026

PDF (778KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉